Glycerol Monolaurate and Dodecylglycerol Effects on Staphylococcus aureus and Toxic Shock Syndrome Toxin-1 In Vitro and In Vivo
Ying-Chi Lin, Patrick M. Schlievert, Michele J. Anderson et al. · 2009
Read Glycerol Monolaurate and Dodecylglycerol Effects on Staphylococcus aureus and Toxic Shock Syndrome Toxin-1 In Vitro and In Vivo by Ying-Chi Lin, Patrick M. Schlievert, Michele J. Anderson et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007499.txt.
Description
Ying-Chi Lin and colleagues published a study in PLOS ONE in 2009 on two fatty compounds that fight Staphylococcus aureus. One, glycerol monolaurate, slows the bacterium's growth and shuts down its toxin output. The toxin in question causes toxic shock syndrome. A flaw limits the first compound: a bacterial enzyme breaks it down. The team compared it with a tougher relative, dodecylglycerol.
They tested both compounds in lab cultures and in living animals. The comparison covered killing power and control of toxic shock toxin-1. A more durable compound would keep working where the first one degrades. That durability matters for uses like skin treatments or protective products. The study weighs whether the sturdier molecule can replace its fragile cousin. It is a practical step toward better anti-staph defenses.
Catalog record
| CREATOR | Ying-Chi Lin, Patrick M. Schlievert, Michele J. Anderson et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007499